Canadian doctors to be ‘slightly altered’ in new test for Ebola

A new test developed by a Canadian doctor may help doctors determine whether a patient may have contracted the Ebola virus.

The Canadian College of Physicians and Surgeons says it will use a blood test in the coming weeks to help determine if a person who tests positive for the virus has Ebola or another strain.

The test was developed by Dr. Patrick Mayne of the University of Toronto.

It’s an advance in the treatment of Ebola that’s been used to test people in the U.S. and other countries.

Mayne said the test has been effective at detecting people infected with the virus but has some limitations.

Mayan said it’s not perfect and the new test may have limitations, but that it’s a useful step.

Mayanne says the test should be used more widely because it’s faster, cheaper and more accurate.

He said the Canadian test has already been used by health officials in several countries.

The tests will be rolled out in other countries later this month.

May, who has been treating patients in Toronto, said the new technology will be used in a few cases where the patient tested negative for Ebola.

He did not say how many of the people infected tested positive for Ebola but said a small number had tested positive.

May is not a medical doctor but said he’s used his experience to help patients diagnosed with the deadly virus.

He has been using the test since late October in Toronto.

May has been working with the University Health Network in Toronto to test about 100 patients a day.

He hopes the test will be tested more widely.

Health officials say there are about 30 people who have tested positive to Ebola.

Those people are being monitored and tested again, and the health agency says it expects to release the results in the next few days.

May said it would take about 30 days for the test results to come out.

He says the Canadian team is now working with U.K. and Canadian health authorities to get their results as quickly as possible.

He’s optimistic that the test could help determine whether the patient who tested positive has Ebola.